Europe and Asia/Pacific to widely differ in future obesity

While it is universally true that the incidence and prevalence of obesity is increasing steadily, it is not nearly as true that the rate of growth is consistent globally and differences in these rates are compounded by differences in the market impact they have for the adoption and growth in the use of obesity treatment products.  Differences in demographics, socioeconomic trends, regulatory environments and other forces result in some starkly different pictures of obesity markets from region to region.

As an example, below are illustrated the distribution of obesity markets (figures in $ millions) by treatment type for Asia/Pacific versus Europe for both 2011 and 2019.  The economic growth of Asia/Pacific markets, particularly China and an associated growth in incidence/prevalence in obesity there will translate into a larger aggregate market for obesity treatments in 2019 for Asia/Pacific than in Europe, reversing the current picture in 2011.

Source: Report #S835, "Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019."